Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

6.7.7 SMC 021 94

6.7.8 Ostora 94

6.7.9 BA058- injection 96

6.7.10 UNI-PH (1-34), rhPTH 1-34 96

6.7.11 YM529 / ONO-5920 --- Astellas/ ONO 97

6.8 Key Takeaway 97

7 Osteoporosis Therapeutics: Clinical Trials Mapping 98

7.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 98

7.2 Clinical Trials by Phase of Clinical Development 99

7.3 Clinical Trials by Trial Status 100

7.4 Prominent Sponsors 101

7.5 Clinical Trials by Sponsors 102

7.6 Top Companies Participating in Osteoporosis Therapeutics Clinical Trials 103

8 Osteoporosis Therapeutics: Strategic Assessment 105

8.1 Key Events Impacting the Future Market 105

8.2 Future Market Competition Scenario 105

9 Osteoporosis Therapeutics: Future Players 108

9.1 Introduction 108

9.2 Company Profiles 108

9.2.1 Amgen Inc. 108

9.2.2 Astellas Pharma, Inc. 111

9.2.3 EffRx, Inc. 113

9.2.4 Merck & Co., Inc. 114

9.2.5 Novartis AG 115

9.2.6 Osteologix, Inc. 117

9.2.7 Pfizer Inc. 118

9.2.8 Radius Health, Inc 122

9.2.9 Tarsa Inc. 123

9.2.10 Zyduscadila Inc. 123

9.3 Other Companies in the Osteoporosis Therapeutics Market 126

9.4 Key Takeaway 129

10 Osteoporosis Therapeutics: Licensing & Partnership Deals 129

11 Osteoporosis Therapeutics: Appendix 140

11.1 Market Definitions 140

11.2 Abbreviations 140

11.3 Research Methodology 142

11.3.1 Coverage 142

11.3.2 Secondary Research 142

11.3.3 Forecasting 143

11.3.4 Primary Research 145

11.3.5 Expert Panel Validation 146

11.4 Contact Us 146

11.5 Disclaimer 146

11.6 Bibliography 147

List of Tables

Table 1: Difference Between Type I and Type II Osteoporosis 19

Table 2: Osteoporosis Prevalence and Low Bone Mass in People Aged 50 and Over (The US) (million
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China , today announced that on ... special cash dividend of US$0.30 per ordinary share (or ... outstanding ordinary shares. The total expense for the special ...
(Date:7/28/2014)... July 28, 2014 ... 2,5 Millionen £ investiert hat, um die ... Gesundheits-, Pharma- und Logistikbranche zu erfüllen. Albion ...      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ) ... OmPrompt sein beschleunigtes Wachstum mit Investitionen in ...
(Date:7/28/2014)... MURRAY HILL and NEW PROVIDENCE, ... management and engineering professionals are invited to meet with ... Conference and Technical Exhibition to be held at McCormick ... August 3-6. "Hospitals demand nothing less ... said Mark Sanda , Linde,s Healthcare Segment manager. ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... , DENVER , Jan. 28 Global ... Board: GLOB), an international healthcare information technology company, today announced ... management software and Donor Doc® health history questionnaire to Community ... Kansas City, Missouri . Terms of the agreement were ...
... , , MOUNTAIN VIEW, Calif. ... announced the initiation of a Phase I clinical trial ... autoimmune diseases.  CCX168 is a highly potent and very ... a component of the body,s complement system and a ...
Cached Medicine Technology:Global Med Technologies(R)' Solution of Choice for Important Regional Blood Center 2Global Med Technologies(R)' Solution of Choice for Important Regional Blood Center 3Global Med Technologies(R)' Solution of Choice for Important Regional Blood Center 4Global Med Technologies(R)' Solution of Choice for Important Regional Blood Center 5ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 2ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 3ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 4
(Date:7/28/2014)... revised version of a surgical procedure to treat severe ... than 90 percent of the time in patients treated ... MGH Division of Plastic and Reconstructive Surgery report that ... non-endoscopic procedure all of whom had headaches associated ... relief a year later. The team,s paper has ...
(Date:7/28/2014)... Braintree, Massachusetts (PRWEB) July 28, 2014 ... the Summit Provider Exchange technology solution ... office integration efforts and support collaboration with their ... 242 bed acute-care medical center located in New ... 800,000 seasonal visitors with a variety of inpatient ...
(Date:7/28/2014)... runners are far more likely to die of heat ... new study. The researchers pointed out that ... actually 10 times more likely to develop severe and ... of a young and apparently healthy person due to ... gets a lot more media attention. "This research ...
(Date:7/28/2014)... July 28, 2014 The Oakwood Foundation ... Birkhill, Wang, Songe and Associates, PC that will benefit ... tomorrows to come. , The HBWS group is ... more than $2.5 million in donations. Through their latest ... for the Oakwood Women’s Healthcare Classic for the next ...
(Date:7/28/2014)... Stimulating one of two dopamine-producing regions in the brain ... either isoflurane or propofol. In the August issue ... (MGH) report that rats anesthetized with continuous doses of ... stand up in response to electrical stimulation delivered to ... other major dopamine-releasing area, the substantia nigra, did not ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2
... CHESHIRE, Conn., Oct. 11 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... conference call and audio web cast on Thursday, October ... with the release of its,financial results for the third ... results at 6:30 a.m. ET on Thursday,October 25, 2007. ...
... Oct. 11 The following was,written by Andrew ... hormonal birth control. Why can Planned,Parenthood freely market ... an increasing array of restrictions?, Fifty years ... were,lethal. Many people smoked, especially highly visible public ...
... The National Medical,Association (NMA) announced the appointment of ... Director of Health Policy, Mr. Sogie-Thomas,will be responsible ... emerging,healthcare trends and current policy issues. He will ... on state and federal law,regulation, and policy. ...
... Chinese undergraduates showed significant benefit , , , THURSDAY, Oct. ... a day for five days helped to increase energy ... of stress hormones, a small study found. , ... from traditional Chinese medicine, the study participants reported better ...
... World Bank report,says in just two years nearly 20 ... doses of artemisinin-based combination therapy (ACT),are on course to ... Control in Africa., The Progress Report on the ... --- including more than 42 million children under,age five ...
... Receives 2007 Distinctively Blue Award for Hospital ... efforts to,reduce hospital-acquired infections in the mid-Atlantic ... from the BlueCross BlueShield,Association of America. CareFirst ... Award for Innovations for the 100,000 Lives ...
Cached Medicine News:Health News:Sue Birth Control Companies for Your Health, Says American Life League 2Health News:Sue Birth Control Companies for Your Health, Says American Life League 3Health News:Sue Birth Control Companies for Your Health, Says American Life League 4Health News:National Medical Association Selects New Director of Health Policy 2Health News:Meditation a Quick Fix for Stress 2Health News:World Bank Group Report on Malaria in Africa Highlights Progress Towards Goal of Significantly Reducing Malaria Deaths 2Health News:World Bank Group Report on Malaria in Africa Highlights Progress Towards Goal of Significantly Reducing Malaria Deaths 3Health News:National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts 2
PremierEdge Stab Knives - 15....
DCR Set, Straight....
... acknowledged to be the easiest to use, ... benefits are due to the exclusive use ... footprint available coupled with advanced electronics and ... reading. Thus corneal thickness measurements can be ...
... The Leica CM1850 cryostat for ... histopathology laboratory is designed for ... workload. A new insulation technology ... the refrigerating system and maintains ...
Medicine Products: